BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

   
Pushing the boundaries of microfluidics - New Expert Advisory Group is formed to advance Dolomite’s growing application areas


10th November 2006 Royston, UK – Following the 2006 formation of The Dolomite Centre Limited, the first Microfluidic Application Centre in the world, Dolomite has announced the creation of a new advisory group to augment its scientific and fabrication expertise. The advisory group will significantly increase Dolomite’s access to capabilities and application areas, with industry-leading professionals from sectors including Pharmaceuticals, Forensic Science, Medicine and Academia.



High resolution picture available from clarer@alto-marketing.com

With an in-depth understanding of chemistry and the life sciences combined with expertise in glass microfabrication and microfluidics, Dolomite offers a complete service, from device fabrication through to full instrument design and development. With the incorporation of the new advisory group, Dolomite aims to make strategic decisions about where to apply its specialist glass, quartz and ceramic technologies and its high performance microfluidics knowledge.

The group members include: Julie Deacon, Micro and Nanotechnology (MNT) Network; Leonard Fass, GE Healthcare; Stephanie Hawkes, GlaxoSmithKline; Andy Hopwood, Forensic Science Service; Graeme Maxwell, Centre for Integrated Photonics (CIP); Andrew de Mello, Imperial College London; and Ian Sturland of BAE Systems. Commenting on the formation of the advisory group, Dolomite Managing Director Mark Gilligan said, “The formation of this new group is of significant value for Dolomite and allows us to make strategic decisions about where best to use microfluidic technology to address novel application areas.” He continued, “The technology will address the current industry demands for improved reproducibility, faster performance and lower reagent consumption.”

Dolomite was recently established as a subsidiary of Syrris Ltd, a leading UK developer of tools and technologies for R&D chemists. Dolomite has been funded with a UK Department of Trade and Industry (Dti) grant of £2 million to become a new facility in the Dti’s Micro and Nanotechnology (MNT) Facilities Network.

www.dolomite-centre.com

www.syrris.com

ENDS

Editors' notes
The Dolomite Centre Ltd


Established in 2005 as a subsidiary of Syrris Ltd (a market leader in the field of Microreactors and productivity improvement for R&D chemistry), Dolomite is a world leader in application, design and fabrication of microfluidic devices. Dolomite is the world’s first microfluidic application centre.

Dolomite absorbed a specialist fabrication company in February 2006 called Scientific Consultants. Dolomite won a grant for £2m from the UK DTi, as part of the MNT (Micro and Nano Technology) programme.

Dolomite operates with a service based business model, and will work with partners in any application space. Examples are: Drug Discovery, Bio-terror, DNA analysis, Analytical Instrumentation, Space, Personal Healthcare and Fashion.

There are three basic services provided:

- Device Fabrication

- Device Design and Fabrication

- Full System Development and Manufacture

Enquiries - Dolomite

Mark Gilligan +44 (0)1763 242 555 Email: mark.gilligan@syrris.com

Media enquiries - Alto Marketing Limited

Clare Russell +44 (0)1489 557672 Email: clarer@alto-marketing.com
 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.